About mivacurium chloride
Short-acting non-depolarizing neuromuscular blocker
Used for
- Relaxes muscles during general anaesthesia to help with surgery and breathing-tube placement
Usual adult dose
Given intravenously by an anaesthesia professional; usual initial dose is 0.15–0.2 mg/kg, adjusted to response.
Usual dose in children
Used in children over 2 months; dosing is weight-based and adjusted by an anaesthesia professional.
Common side effects
- Low blood pressure
- Flushing
- Fast heartbeat
- Prolonged muscle weakness or breathing difficulty
Important warnings
- Causes paralysis, including inability to breathe; requires ventilation and close monitoring.
- Must be given by trained anaesthesia professionals with resuscitation equipment available.
- Can release histamine, especially with rapid or larger doses.
- Use caution with neuromuscular disorders, burns, or significant kidney or liver impairment.
Pregnancy
Use only when clearly needed; human pregnancy information is limited.
Breastfeeding
There is limited information; discuss use with a healthcare professional.
Interactions
- Anaesthetic medicines and some antibiotics can intensify or prolong paralysis.
- Other neuromuscular blockers can intensify or prolong its effects.
- Medicines that inhibit cholinesterase may reverse or alter its effects.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.